Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 138

Sort by

Sort Order Select

Journal Articles

Cytokine-Inducible SH2-Containing Protein (CISH) Is an Intracellular Immune Checkpoint That Controls T Regulatory Cells in Splenic Marginal Zone Lymphoma

Xinyi Tang, Zhi-Zhang Yang, Yue Yu, Xiaosheng Wu, Vaishali Bhardwaj, Prithviraj Mukherjee, Patrizia Mondello, Hyojin Kim, Anne J. Novak, Stephen M. Ansell

Blood (2024) 144 (Supplement 1): 1618.

https://doi.org/10.1182/blood-2024-208187

Published: 2024

Journal Articles

Subsets of Follicular Lymphoma (FL) 3B Have Divergent Biological Behavior and Clinical Outcome: Results from the Prospective Multicenter MER and LEO Cohorts

Blood (2024) 144 (Supplement 1): 1629.

https://doi.org/10.1182/blood-2024-194681

Published: 2024

Journal Articles

Subtype-Specific Mechanisms of Treatment Resistance and Relapse in Diffuse Large B Cell Lymphoma (DLBCL)

Blood (2024) 144 (Supplement 1): 2977.

https://doi.org/10.1182/blood-2024-208182

Published: 2024

Journal Articles

Assessment of the Optimized HLH Inflammatory (OHI) Index in a Prospective Cohort of Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma

Adi Zoref-Lorenz, Elliot J Cahn, Eric Mou, Yucai Wang, Matthew J. Maurer, Andrew L. Feldman, Bri J Negaard, Raphael Mwangi, Gilad Itchaki, Grzegorz S. Nowakowski, Thomas M. Habermann, Brian K. Link, Stephen M. Ansell, Anne J. Novak, Gaurav Goyal, Thomas E. Witzig, James R. Cerhan, Michael B. Jordan

Blood (2024) 144 (Supplement 1): 1624.

https://doi.org/10.1182/blood-2024-210119

Published: 2024

Journal Articles

Role of Clonal Hematopoiesis (CH) in Lymphoma: Prevalence and Clinical Impact in Follicular Lymphoma (FL) and Diffuse Large B-Cell Lymphoma (DLBCL)

Gonzalo Lopez, Nicholas J. Boddicker, Rahat Hasan, Chris Huang, Arnaud Amzallag, Rajasekhar N.V.S. Suragani, Anita K. Gandhi, Anne J. Novak, James R. Cerhan, Maroof Hasan

Blood (2024) 144 (Supplement 1): 2967.

https://doi.org/10.1182/blood-2024-204336

Published: 2024

Journal Articles

Polymorphonuclear Myeloid-Derived Suppressor Cells Promote Tumor Cell Survival and Suppress Cytotoxic T- Cells in Waldenström Macroglobulinemia

Vaishali Bhardwaj, Zhi-Zhang Yang, Prithviraj Mukherjee, Rekha Mudappathi, Junewen Wang, Xinyi Tang, Jonas Paludo, Anne J. Novak, Patrizia Mondello, Stephen M. Ansell

Blood (2024) 144 (Supplement 1): 5661.

https://doi.org/10.1182/blood-2024-208966

Published: 2024

Journal Articles

Multi-Omics DNA Methylation Analysis of MYD88 Wild-Type Waldenstrom Macroglobulinemia Reveals Potential Epigenetic Influence on Oncogenic Pathways

Blood (2024) 144 (Supplement 1): 6201.

https://doi.org/10.1182/blood-2024-205509

Published: 2024

Journal Articles

Multiomics analysis of IgM monoclonal gammopathies reveals epigenetic influence on oncogenesis via DNA methylation

Blood (2024) 144 (12): 1284–1289.

https://doi.org/10.1182/blood.2023023639

Published: 2024

Includes: Supplemental data

Journal Articles

DEK Regulates B-Cell Proliferative Capacity and Is Associated with Aggressive Disease in Low-Grade B-Cell Lymphoma

Melissa A. Hopper, Abigail R. Dropik, Janek S. Walker, Joseph P. Novak, Miranda S. Laverty, Michelle Manske, Xiaosheng Wu, Kerstin Wenzl, Jordan Edward Krull, Vivekananda Sarangi, Matthew J. Maurer, Thomas M. Habermann, Brian K. Link, Lisa M. Rimsza, Thomas E. Witzig, Stephen M Ansell, James R. Cerhan, Dragan Jevremovic, Anne J. Novak

Blood (2023) 142 (Supplement 1): 4360.

https://doi.org/10.1182/blood-2023-180232

Published: 2023

Journal Articles

Molecular Classification of Relapsed DLBCL Reveals Novel Biologic Subgroups

Blood (2023) 142 (Supplement 1): 2770.

https://doi.org/10.1182/blood-2023-180949

Published: 2023

Journal Articles

Tumor Mutational Burden As a Prognostic Factor in Diffuse Large B-Cell Lymphoma

Rosalie Griffin, Kerstin Wenzl, Vivekananda Sarangi, Lisa M. Rimsza, Rebecca King, Andrew L. Feldman, Matthew J. Maurer, Grzegorz S. Nowakowski, Brian K. Link, Thomas M. Habermann, Nicholas Stong, C. Chris Huang, Anita K. Gandhi, Susan L. Slager, Anne J. Novak, James R. Cerhan

Blood (2023) 142 (Supplement 1): 1633.

https://doi.org/10.1182/blood-2023-182291

Published: 2023

Journal Articles

IRF4 Rewires Tumor Metabolism with Functional Implications on the Immune Microenvironment in Lymphoma

Patrizia Mondello, Vaishali Bhardwaj, Kerstin Wenzl, Joshua Olson, Christine Hachfeld, Prithviraj Mukherjee, Xinyi Tang, Joseph P. Novak, Zhi-Zhang Yang, Megan Weivoda, Nicholas Graham, Laura Pasqualucci, Mark Shlomchik, Anne J. Novak, Stephen M Ansell

Blood (2023) 142 (Supplement 1): 1643.

https://doi.org/10.1182/blood-2023-178120

Published: 2023

Journal Articles

Genome-Wide DNA Methylation Analysis Reveals Epigenetic Influence on Intracellular and Cytokine Signaling Pathways in Waldenström Macroglobulinemia Compared to IgM-MGUS

Blood (2023) 142 (Supplement 1): 1622.

https://doi.org/10.1182/blood-2023-182874

Published: 2023

Journal Articles

Truncating SPEN Mutations Highlight BN2-Subtype DLBCL with Aggressive Biology and Features of Immune Evasion

Blood (2023) 142 (Supplement 1): 4140.

https://doi.org/10.1182/blood-2023-181974

Published: 2023

Journal Articles

Lymphoid Malignancy Risk with Rare Inherited Variants in Known Cancer Predisposition Genes

Blood (2023) 142 (Supplement 1): 2990.

https://doi.org/10.1182/blood-2023-182266

Published: 2023

Journal Articles

Prediction of Early Disease Progression at 24 Months (POD24) Using Pre-Treatment Biopsies from Patients with Follicular Lymphoma (FL) Treated with Immunochemotherapy (IC)

George W. Wright, Colleen A. Ramsower, James R. Cerhan, Anne J. Novak, Brian K. Link, Matthew J. Maurer, Raphael Mwangi, Allison C. Rosenthal, Thomas M. Habermann, Lou Staudt, Robert Kridel, David W. Scott, Christian Steidl, Lisa M. Rimsza

Blood (2022) 140 (Supplement 1): 6426–6427.

https://doi.org/10.1182/blood-2022-160351

Published: 2022

Journal Articles

Biological Features of a High-Risk Transcriptional Molecular Subtype in Diffuse Large B-Cell Lymphoma

Blood (2022) 140 (Supplement 1): 3548–3550.

https://doi.org/10.1182/blood-2022-170228

Published: 2022

Journal Articles

Genomic Pathways Differentiating IgM-MGUS from Waldenstrom Macroglobulinemia: The Integrated microRNA and Gene Expression Landscape

Karan Chohan, Jonas Paludo, Surendra Dasari, Jithma P. Abeykoon, Prashant Kapoor, Esteban Braggio, Michelle K. Manske, Aneel Paulus, Craig B. Reeder, Sikander Ailawadhi, Asher Chanan-Khan, Robert A. Kyle, Morie A Gertz, Anne J. Novak, Stephen M. Ansell

Blood (2022) 140 (Supplement 1): 9242–9243.

https://doi.org/10.1182/blood-2022-167543

Published: 2022

Journal Articles

A Genome-Wide Association Study (GWAS) of Event-Free Survival (EFS) in Follicular Lymphoma Patients Treated with Front-Line Immunochemotherapy: A Lysa, Iowa/Mayo MER, and FIL Study

Herve Ghesquieres, Youenn Drouet, Susan L. Slager, Franck Morschhauser, Sara Galimberti, Dennis P. Robinson, Emilie Thomas, Anne J. Novak, Luc Xerri, Stefano Luminari, Aurelie Verney, Camille Laurent, Lisa M. Rimsza, Thomas M. Habermann, Massimo Federico, Brian K. Link, Gilles Salles, James R. Cerhan

Blood (2022) 140 (Supplement 1): 1307–1309.

https://doi.org/10.1182/blood-2022-167466

Published: 2022

Journal Articles

Single Cell RNA-Seq of Extranodal Marginal Zone Lymphoma (MZL) Identifies Site-Specific and Shared Features in Both B and T Cell Components

Luciano Cascione, Afua Adjeiwaa Mensah, Alberto Arribas, Davide Rossi, Emanuele Zucca, Giorgio Inghirami, Anne J. Novak, Francesco Bertoni

Blood (2022) 140 (Supplement 1): 3508–3509.

https://doi.org/10.1182/blood-2022-160223

Published: 2022

NARROW

Cytokine-Inducible SH2-Containing Protein (CISH) Is an Intracellular Immune Checkpoint That Controls T Regulatory Cells in Splenic Marginal Zone Lymphoma

Subsets of Follicular Lymphoma (FL) 3B Have Divergent Biological Behavior and Clinical Outcome: Results from the Prospective Multicenter MER and LEO Cohorts

Subtype-Specific Mechanisms of Treatment Resistance and Relapse in Diffuse Large B Cell Lymphoma (DLBCL)

Assessment of the Optimized HLH Inflammatory (OHI) Index in a Prospective Cohort of Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma

Role of Clonal Hematopoiesis (CH) in Lymphoma: Prevalence and Clinical Impact in Follicular Lymphoma (FL) and Diffuse Large B-Cell Lymphoma (DLBCL)

Polymorphonuclear Myeloid-Derived Suppressor Cells Promote Tumor Cell Survival and Suppress Cytotoxic T- Cells in Waldenström Macroglobulinemia

Multi-Omics DNA Methylation Analysis of MYD88 Wild-Type Waldenstrom Macroglobulinemia Reveals Potential Epigenetic Influence on Oncogenic Pathways

Multiomics analysis of IgM monoclonal gammopathies reveals epigenetic influence on oncogenesis via DNA methylation

DEK Regulates B-Cell Proliferative Capacity and Is Associated with Aggressive Disease in Low-Grade B-Cell Lymphoma

Molecular Classification of Relapsed DLBCL Reveals Novel Biologic Subgroups

Tumor Mutational Burden As a Prognostic Factor in Diffuse Large B-Cell Lymphoma

IRF4 Rewires Tumor Metabolism with Functional Implications on the Immune Microenvironment in Lymphoma

Genome-Wide DNA Methylation Analysis Reveals Epigenetic Influence on Intracellular and Cytokine Signaling Pathways in Waldenström Macroglobulinemia Compared to IgM-MGUS

Truncating SPEN Mutations Highlight BN2-Subtype DLBCL with Aggressive Biology and Features of Immune Evasion

Lymphoid Malignancy Risk with Rare Inherited Variants in Known Cancer Predisposition Genes

Prediction of Early Disease Progression at 24 Months (POD24) Using Pre-Treatment Biopsies from Patients with Follicular Lymphoma (FL) Treated with Immunochemotherapy (IC)

Biological Features of a High-Risk Transcriptional Molecular Subtype in Diffuse Large B-Cell Lymphoma

Genomic Pathways Differentiating IgM-MGUS from Waldenstrom Macroglobulinemia: The Integrated microRNA and Gene Expression Landscape

A Genome-Wide Association Study (GWAS) of Event-Free Survival (EFS) in Follicular Lymphoma Patients Treated with Front-Line Immunochemotherapy: A Lysa, Iowa/Mayo MER, and FIL Study

Single Cell RNA-Seq of Extranodal Marginal Zone Lymphoma (MZL) Identifies Site-Specific and Shared Features in Both B and T Cell Components

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only